«This study provided clear evidence that, in people with early Parkinson disease, inosine treatment can safely elevate
urate levels in the blood and cerebrospinal
fluid for months or years,» says Michael Schwarzschild, MD, PhD, principal investigator of the study and an MGH neurologist.